Status:
UNKNOWN
China Rheumatoid Arthritis Registry of Patients With Chinese Medicine
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
A multi-center registration study of clinical characteristics of rheumatoid arthritis (RA) patients with Chinese medicine.
Eligibility Criteria
Inclusion
- Fulfilled the rheumatoid arthritis classification criteria of 2010 American College of Rheumatology (ACR)/the European League Against Rheumatism (EULAR) .
- Aged 18 years and older.
- Be willing to accept CM therapies defined as Chinese herbal medicine, Chinese patent medicine, external treatment, acupuncture and moxibustion, etc
Exclusion
- Refuse informed consent.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
12000 Patients enrolled
Trial Details
Trial ID
NCT05219214
Start Date
September 1 2019
End Date
December 31 2024
Last Update
February 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Beijing, China, 100053